The food industry considers GLP-1s

Lawmakers have to approve a new law, which is mixed on how much taxpayers should foot the bill for healthy foods, while food manufacturers are revising their strategies for the weight-loss drug era.

Exclusive: Amazon's Health AI Bot Exposes a Flaw in Patient Data Access

Experts are weighing the ethics and security vulnerabilities of allowing bots to access patient data as doctors do.

AI drug discovery’s expensive reality

Rising compute costs have biotech firms rethinking how they use large language models.

Oura’s IPO Could Become a Watershed Moment for Women’s Health

From fertility and menopause to sleep and recovery, Oura is building one of the largest consumer health datasets focused on women.

The Food and Drug Administration in free fall

Plus: updates on the Ebola outbreak, CMS' prior authorization program, and Healthcare.gov

Healthcare adopts the New Media playbook by hiring in-house journalists

Plus all the most important news of the week!

Former FDA Deputy weighs in on the push into ‘real-time clinical trials’

There’s reason to be excited - even if it seems incremental

AI and the rise of specialty care

Scientists want evidence for AI in medicine

Patients may not care.

An inside look at Epic’s confidential vendor services agreement

CMS announces ACCESS participants

There's a lot more of them than we expected!

Health systems don’t have time for a bunch of different AI products

Epic’s algorithms aren’t performing well in the real world, study shows

AI in Healthcare Is Scaling Fast - Here’s What You Need to Know